

[ Tue, Nov 24th 2020
] - WOPRAI
[ Tue, Nov 24th 2020
] - WOPRAI

[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI

[ Fri, Nov 20th 2020
] - WOPRAI
[ Fri, Nov 20th 2020
] - WOPRAI
[ Fri, Nov 20th 2020
] - WOPRAI
Vincent Chen Initiated (VRTX) at Buy and Held Target at $275 on, Nov 20th, 2020
Vincent Chen of Bernstein, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $275 on, Nov 20th, 2020.
Vincent has made no other calls on VRTX in the last 4 months.
There are 9 other peers that have a rating on VRTX. Out of the 9 peers that are also analyzing VRTX, 3 agree with Vincent's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Abrahams of "RBC Capital" Maintained at Hold and Held Target at $247 on, Tuesday, November 17th, 2020
- Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $257 on, Friday, October 30th, 2020
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $249 on, Monday, October 19th, 2020
These are the ratings of the 6 analyists that currently disagree with Vincent
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $285 on, Friday, October 30th, 2020
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $307 on, Friday, October 30th, 2020
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $277 on, Friday, October 30th, 2020
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $305 on, Thursday, October 15th, 2020
- Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $305 on, Friday, July 31st, 2020
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $315 on, Friday, July 31st, 2020